Rachel A. O’Keefe

3.5k total citations · 1 hit paper
12 papers, 2.4k citations indexed

About

Rachel A. O’Keefe is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Rachel A. O’Keefe has authored 12 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 5 papers in Molecular Biology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Rachel A. O’Keefe's work include Lung Cancer Treatments and Mutations (4 papers), Tuberous Sclerosis Complex Research (2 papers) and Genetics and Neurodevelopmental Disorders (2 papers). Rachel A. O’Keefe is often cited by papers focused on Lung Cancer Treatments and Mutations (4 papers), Tuberous Sclerosis Complex Research (2 papers) and Genetics and Neurodevelopmental Disorders (2 papers). Rachel A. O’Keefe collaborates with scholars based in United States and China. Rachel A. O’Keefe's co-authors include Jennifer R. Grandis, Daniel E. Johnson, Christopher M. Bartley, Angélique Bordey, Neil E. Bhola, Toni M. Brand, Yan Zeng, Nathaniel W. Hartman, David M. Feliciano and Carlos Lafourcade and has published in prestigious journals such as Journal of Clinical Investigation, PLoS ONE and Cancer Research.

In The Last Decade

Rachel A. O’Keefe

12 papers receiving 2.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Targeting the IL-6/JAK/STAT3 signalling axis in cancer

2018 2.2k citations Daniel E. Johnson, Rachel A. O’Keefe et al. Nature Reviews Clinical Oncology profile →

Peers

Countries citing papers authored by Rachel A. O’Keefe

Since Specialization

Citations

This map shows the geographic impact of Rachel A. O’Keefe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rachel A. O’Keefe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rachel A. O’Keefe more than expected).

Fields of papers citing papers by Rachel A. O’Keefe

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rachel A. O’Keefe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rachel A. O’Keefe. The network helps show where Rachel A. O’Keefe may publish in the future.

Co-authorship network of co-authors of Rachel A. O’Keefe

This figure shows the co-authorship network connecting the top 25 collaborators of Rachel A. O’Keefe. A scholar is included among the top collaborators of Rachel A. O’Keefe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rachel A. O’Keefe. Rachel A. O’Keefe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

#	Work	Indexed citations
1	The differential interactomes of the KRAS splice variants identify BIRC6 as a ubiquitin ligase for KRAS4A 2024 ·Cell Reports ·Juan Andres Kochen Rossi, Cristina Nuevo‐Tapioles, Rachel A. O’Keefe, Moritz Hunkeler, Anna M. Schmoker, (unknown), Wenjuan Su, Ian M. Ahearn, Cristina Branco, (unknown), Dominic Esposito, (unknown), Beatrix Ueberheide, Eric S. Fischer, Mark R. Philips	1
2	RAB27B controls palmitoylation-dependent NRAS trafficking and signaling in myeloid leukemia 2023 ·Journal of Clinical Investigation ·Jian‐Gang Ren, Bowen Xing, Kaosheng Lv, Rachel A. O’Keefe, Meng‐Fang Wu, Ruoxing Wang, Kaylyn M. Bauer, Arevik Ghazaryan, George M. Burslem, Jing Zhang, Ryan M. O’Connell, Vinodh Pillai, Elizabeth O. Hexner, Mark R. Philips, Wei Tong	24
3	Interleukin 6 is increased in preclinical HNSCC models of acquired cetuximab resistance, but is not required for maintenance of resistance 2020 ·PLoS ONE ·Rachel A. O’Keefe, Neil E. Bhola, David S. Lee, Daniel E. Johnson, Jennifer R. Grandis	5
4	Cross-talk Signaling between HER3 and HPV16 E6 and E7 Mediates Resistance to PI3K Inhibitors in Head and Neck Cancer 2018 ·Cancer Research ·Toni M. Brand, Stefan Hartmann, Neil E. Bhola, Hua Li, Yan Zeng, Rachel A. O’Keefe, Max V. Ranall, Sourav Bandyopadhyay, Margaret Soucheray, Nevan J. Krogan, Carolyn Kemp, Umamaheswar Duvvuri, Theresa LaVallee, Daniel E. Johnson, Michelle A. Ozbun, Julie E. Bauman, Jennifer R. Grandis	31
5	Abstract 1972: Targeting the IL-6 signaling pathway overcomes cetuximab resistance in head and neck squamous cell carcinoma 2018 ·Cancer Research ·Rachel A. O’Keefe, Neil E. Bhola, David Lee, Daniel E. Johnson, Jennifer R. Grandis	1
6	BET Inhibition Overcomes Receptor Tyrosine Kinase–Mediated Cetuximab Resistance in HNSCC 2018 ·Cancer Research ·Brandon Leonard, Toni M. Brand, Rachel A. O’Keefe, (unknown), Yan Zeng, (unknown), Hua Li, Jennifer R. Grandis, Neil E. Bhola	70
7	Targeting the IL-6/JAK/STAT3 signalling axis in cancer breakdown → 2018 ·Nature Reviews Clinical Oncology ·Daniel E. Johnson, Rachel A. O’Keefe, Jennifer R. Grandis	2164
8	Biochemical Properties of a Decoy Oligodeoxynucleotide Inhibitor of STAT3 Transcription Factor 2018 ·International Journal of Molecular Sciences ·David S. Lee, Rachel A. O’Keefe, Patrick K. Ha, Jennifer R. Grandis, Daniel E. Johnson	9
9	Abstract 4108: Targeting IL-6 signaling overcomes cetuximab resistance in head and neck squamous cell carcinoma 2017 ·Cancer Research ·Rachel A. O’Keefe, Neil E. Bhola, Toni M. Brand, Yan Zeng, Daniel E. Johnson, Jennifer R. Grandis	1
10	Mammalian FMRP S499 Is Phosphorylated by CK2 and Promotes Secondary Phosphorylation of FMRP 2016 ·eNeuro ·Christopher M. Bartley, Rachel A. O’Keefe, (unknown), Mihaela‐Rita Mihailescu, Xuan Gong, (unknown), Esra Karaca, Angélique Bordey	31
11	FMRP S499 Is Phosphorylated Independent of mTORC1-S6K1 Activity 2014 ·PLoS ONE ·Christopher M. Bartley, Rachel A. O’Keefe, Angélique Bordey	32
12	A circuitry and biochemical basis for tuberous sclerosis symptoms: from epilepsy to neurocognitive deficits 2013 ·International Journal of Developmental Neuroscience ·David M. Feliciano, Tiffany V. Lin, Nathaniel W. Hartman, Christopher M. Bartley, Cathryn Kubera, Lawrence S. Hsieh, Carlos Lafourcade, Rachel A. O’Keefe, Angélique Bordey	70

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact